COVID-19 vaccines are supposed to be critical measure for ending the pandemic.Governments had to decide on the type of vaccine to provide for their population.In this decision-making process, cost-effectiveness analysis is considered a helpful tool.This study is moondrop quarks a cost-effectiveness analysis utilized to calculate the incremental cost per averted disability-adjusted life year (DALY) by vaccination compared to no vaccination for different COVID-19 vaccines.
The incremental cost-effectiveness ratio (ICER) for a vaccination with COVID-19 vaccines was estimated at 6.2 to 121.2 USD to avert one DALY and 566.8 to 10,957.
7 USD per one death.The lowest and highest ICERs belong to Ad26.COV2.S and CoronaVac, respectively.
Considering the scenario of Iran, vaccines that are recommended include ad26.cov2.s, chadox1-S, rAd26-S + rAd5-S, and BNT162b2 in click here the order of recommendation.